A Phase IIa Double-blind, Placebo Controlled Study of Extended-release Niacin for Stroke Recovery

被引：0
|
作者：
Russman, Andrew N.
Silver, Brian
Katramados, Angelos
Chopp, Michael
Burmeister, Charlotte
Schultz, Lonni
Mitsias, Panayiotis
机构：
来源：
STROKE | 2018年 / 49卷
关键词：
Stroke; Rehabilitation; HDL elevating therapies; Infarction; Clinical trials;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
WP156
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial
    Wang, Kang-Ling
    Fang, Chih-Yuan
    Lai, Wen-Ter
    Wang, Tzung-Dau
    Ueng, Kwo-Chang
    Wang, Kuo-Yang
    Wang, Ji-Hung
    Shyu, Kou-Gi
    Chiang, Chern-En
    ACTA CARDIOLOGICA SINICA, 2021, 37 (02) : 186 - 194
  • [2] A DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY WITH ALPRAZOLAM AND EXTENDED-RELEASE ALPRAZOLAM IN THE TREATMENT OF PANIC DISORDER
    PECKNOLD, J
    LUTHE, L
    MUNJACK, D
    ALEXANDER, P
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1994, 14 (05) : 314 - 321
  • [3] Divalproex extended-release in adolescent migraine prophylaxis: Results of a randomized, double-blind, placebo-controlled study
    Apostol, George
    Cady, Roger K.
    Laforet, Genevieve A.
    Robieson, Weining Z.
    Olson, Evelyn
    Abi-Saab, Walid M.
    Saltarelli, Mario
    HEADACHE, 2008, 48 (07): : 1012 - 1025
  • [4] A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder
    Pollack, Mark H.
    Lepola, Ulla
    Koponen, Hamm
    Simon, Naomi M.
    Worthington, John J.
    Emilien, Gerard
    Tzanis, Evan
    Salinas, Eliseo
    Whitaker, Timothy
    Gao, Bo
    DEPRESSION AND ANXIETY, 2007, 24 (01) : 1 - 14
  • [5] Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia
    Canuso, Carla M.
    Dirks, Bryan
    Carothers, Jennifer
    Kosik-Gonzalez, Colette
    Bossie, Cynthia A.
    Zhu, Young
    Damaraju, C. V.
    Kalali, Amir H.
    Mahmoud, Ramy
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (06): : 691 - 701
  • [6] Venlaflaxine extended-release capsules in panic disorder - Flexible-dose, double-blind, placebo-controlled study
    Bradwejn, J
    Ahokas, A
    Stein, DJ
    Salinas, E
    Emilien, G
    Whitaker, T
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 352 - 359
  • [7] A Phase IIb Double-blind, Randomized, Placebo Controlled Study of GSK249320 for Stroke Recovery
    Cramer, Steven C.
    Enney, Lori A.
    Russell, Colleen K.
    Simeoni, Monica
    Thompson, Thomas R.
    STROKE, 2017, 48
  • [8] Efficacy and safety of extended-release niacin for the treatment of dyslipidemia associated with type 2 diabetes in Chinese: A randomized, double-blind, placebo-controlled trial
    Lu, Chieh-Hsiang
    Hua, Shih-Che
    Chiang, Yi-Der
    Chuan, Lee-Min
    DIABETES, 2008, 57 : A651 - A651
  • [9] A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD
    Johnson, Janet K.
    Liranso, Tesfaye
    Saylor, Keith
    Tulloch, Gabriela
    Adewole, Toyin
    Schwabe, Stefan
    Nasser, Azmi
    Findling, Robert L.
    Newcorn, Jeffrey H.
    JOURNAL OF ATTENTION DISORDERS, 2020, 24 (02) : 348 - 358
  • [10] A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder
    Sambunaris, Angelo
    Bose, Anjana
    Gommoll, Carl P.
    Chen, Changzheng
    Greenberg, William M.
    Sheehan, David V.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 47 - 56
12345